Anti-LAG-3 Antibody LBL-007 plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial
抗LAG-3抗体LBL-007联合替雷利珠单抗和化疗作为晚期鼻咽癌一线治疗:一项多中心II期试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-2054
Sun, Dongchen; Chen, Gang; Chen, Yu; Qu, Song; Liu, Lei; Yang, Kunyu; Li, Jingao; Chen, Lisha; Huang, Xiaoming; Zhu, Haisheng; Tang, Wenjun; Wang, Rensheng; Han, Yaqian; Hu, Desheng; Gao, Jin; Chen, Xiaozhong; Xiong, Hailin; Chen, Wu; Fan, Bin; Cai, Shengli; Kang, Xiaoqiang; Zhang, Li; Yang, Yunpeng